Produktname:18-[[(1S)-1-carboxy-4-[2-[2-[2-[2-[2-[2-(2,5-dioxopyrrolidin-1-yl)oxy-2-oxo-ethoxy]ethoxy]ethylamino]-2-oxo-ethoxy]ethoxy]ethylamino]-4-oxo-butyl]amino]-18-oxo-octadecanoic acid
IUPAC Name:17-{[(1S)-1-carboxy-3-({2-[2-({[2-(2-{2-[(2,5-dioxopyrrolidin-1-yl)oxy]-2-oxoethoxy}ethoxy)ethyl]carbamoyl}methoxy)ethoxy]ethyl}carbamoyl)propyl]carbamoyl}heptadecanoic acid
- CAS:1169630-40-3
- Molekulare Formel:C39H66N4O15
- Reinheit:95%+
- Katalognummer:CM457576
- Molekulargewicht:830.97
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:1169630-40-3
- Molekulare Formel:C39H66N4O15
- Schmelzpunkt:-
- SMILES-Code:OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)ON1C(=O)CCC1=O)C(O)=O
- Dichte:
- Katalognummer:CM457576
- Molekulargewicht:830.97
- Siedepunkt:
- Mdl-Nr.:MFCD32704903
- Lagerung:
Category Infos
- Fatty Acid Modified Side Chains
- Fatty acid-modified side chains are small molecule modifiers and are one of the important factors that change the pharmacokinetic behavior of insulin products. Peptide drugs have the problem of short half-life and easy degradation in clinical practice. Introducing fatty acid-modified side chains into peptide drugs can increase the hydrophobicity of the drug and increase the biological half-life, thereby reducing the dosage and frequency of medication.